![OLCOAS logoS-2_edited.png](https://static.wixstatic.com/media/cea2bd_c425ae7494a24004a27a2a9500d5e3f5~mv2.png/v1/crop/x_0,y_433,w_1563,h_689/fill/w_150,h_66,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/OLCOAS%20logoS-2_edited.png)
Glioblastoma Therapeutic Modalities and Proposed Management Protocol
Bekralas Houria 1*, Dr. Habchi Nawel 2
1: Head of Department of Neurosurgery Bejaia Hospital, Bejaia, Algeria
2: Neurosurgery Department, Mustapha Pacha University Hospital, Algiers, Algeria
Abstract:
Glioblastomas are the most common brain tumors in adults. They generally affect adults between the ages of 45 and 65. Treatment of these tumors involves a combination of surgery, radiotherapy and chemotherapy. The prognosis for these processes is usually poor; however, in recent years we have seen advances in the field of clinical research and molecular biology in particular, which give us a glimpse of a glimmer of hope. Prognostic factors have been identified and they make it possible to set up a therapeutic strategy as well as to have an idea of the response to treatment. We report the results of a prospective series of 500 patients operated on by the same surgical team and attempt to propose a management protocol that can serve as a basis for multi-center studies.
Keywords: Glioblastoma, Surgery, Stupp Protocol, Prognostic factors.